得到的还会哄
2020-10-13
这篇文章不错,转发给大家看
Royal Caribbean, Emergent BioSolutions leads premarket losers' pack
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":309111302,"tweetId":"309111302","gmtCreate":1602596782106,"gmtModify":1703827109266,"author":{"id":3560860629444699,"authorId":3560860629444699,"authorIdStr":"3560860629444699","name":"得到的还会哄","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>\n这篇文章不错,转发给大家看</body></html>","htmlText":"<html><head></head><body>\n这篇文章不错,转发给大家看</body></html>","text":"这篇文章不错,转发给大家看","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/309111302","repostId":2075334968,"repostType":2,"repost":{"id":"2075334968","pubTimestamp":1602591408,"share":"https://www.laohu8.com/m/news/2075334968?lang=&edition=full","pubTime":"2020-10-13 20:16","market":"us","language":"en","title":"Royal Caribbean, Emergent BioSolutions leads premarket losers' pack","url":"https://stock-news.laohu8.com/highlight/detail?id=2075334968","media":"Meghavi Singh","summary":"Gossamer Bio (NASDAQ:GOSS) -32% after two studies in GB001, Phase 2B LEDA trial in eosinophilic asth","content":"<html><body><div><div>\n<p>Gossamer Bio <span>(NASDAQ:GOSS)</span> <font color=\"red\">-32%</font> after two studies in GB001, Phase 2B LEDA trial in eosinophilic asthma and Phase 2 TITAN trial in chronic rhinosinusitis, failed to meet the primary endpoints.</p>\n<p>Wah Fu Education <span>(NASDAQ:WAFU)</span> <font color=\"red\">-23%</font>.</p>\n<p>Hexindai <span>(NASDAQ:HX)</span> <font color=\"red\">-20%</font>.</p>\n<p><a href=\"https://laohu8.com/S/MDLY\">Medley Management</a> <span>(NYSE:MDLY)</span> <font color=\"red\">-19%</font>.</p>\n<p>Iconix Brand Group <span>(NASDAQ:ICON)</span> <font color=\"red\">-13%</font>.</p>\n<p>Emergent BioSolutions <span>(NYSE:EBS)</span> <font color=\"red\">-8%</font>.</p>\n<p>Greenpro Capital <span>(NASDAQ:GRNQ)</span> <font color=\"red\">-8%</font>.</p>\n<p>Royal Caribbean <span>(NYSE:RCL)</span> <font color=\"red\">-6%</font> after commencing public offering.</p> </div><div><p><b>See all stocks on the move »</b></p></div><div><p>Now read: <b><a href=\"https://laohu8.com/S/CTLT\">Catalent</a> Inc.: Taking Advantage Of COVID-19 Opportunities »</b></p></div></div></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Royal Caribbean, Emergent BioSolutions leads premarket losers' pack</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRoyal Caribbean, Emergent BioSolutions leads premarket losers' pack\n</h2>\n\n<h4 class=\"meta\">\n\n\n2020-10-13 20:16 GMT+8 <a href=https://seekingalpha.com/news/3621638-royal-caribbean-emergent-biosolutions-leads-premarket-losers-pack><strong>Meghavi Singh</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Gossamer Bio (NASDAQ:GOSS) -32% after two studies in GB001, Phase 2B LEDA trial in eosinophilic asthma and Phase 2 TITAN trial in chronic rhinosinusitis, failed to meet the primary endpoints.\nWah Fu ...</p>\n\n<a href=\"https://seekingalpha.com/news/3621638-royal-caribbean-emergent-biosolutions-leads-premarket-losers-pack\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GOSS":"Gossamer Bio Inc.","WAFU":"华富教育","GRNQ":"Greenpro Capital Corp.","EBS":"Emergent Biosolutions","ICON":"Icon Energy Corp.","RCL":"皇家加勒比邮轮"},"source_url":"https://seekingalpha.com/news/3621638-royal-caribbean-emergent-biosolutions-leads-premarket-losers-pack","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2075334968","content_text":"Gossamer Bio (NASDAQ:GOSS) -32% after two studies in GB001, Phase 2B LEDA trial in eosinophilic asthma and Phase 2 TITAN trial in chronic rhinosinusitis, failed to meet the primary endpoints.\nWah Fu Education (NASDAQ:WAFU) -23%.\nHexindai (NASDAQ:HX) -20%.\nMedley Management (NYSE:MDLY) -19%.\nIconix Brand Group (NASDAQ:ICON) -13%.\nEmergent BioSolutions (NYSE:EBS) -8%.\nGreenpro Capital (NASDAQ:GRNQ) -8%.\nRoyal Caribbean (NYSE:RCL) -6% after commencing public offering. See all stocks on the move »Now read: Catalent Inc.: Taking Advantage Of COVID-19 Opportunities »","news_type":1},"isVote":1,"tweetType":1,"viewCount":342,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":25,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/309111302"}
精彩评论